ReviewESMO gastrointestinal oncology2025

Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies.

L Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.